Skip to main content
. 2018 Apr 17;13(4):e0195733. doi: 10.1371/journal.pone.0195733

Table 1. Battery of clinical assessments for degenerative cervical myelopathy.

Clinical Measure Description
mJOA Score[2] 18-point ordinal scale of neurological impairment including subscores for upper extremity motor function, lower extremity motor function (gait), upper extremity sensory function, and urinary function
QuickDASH[34] 44-point interval scale for upper limb function, pain, and effects on quality of life
ISNCSCI UEMS[39] 50-point interval scale for neurological function of the upper limb (power in 10 myotomes), administered separately for each upper limb
JAMAR Grip Dynamometer[32] Measures maximal grip force in each hand; calculated as average of 3 measurements
GRASSP-M[33] Dexterity testing of each hand to place four metallic nuts on screws, scored for precision, grasp, number of drops, and completeness (9 points), and time to completion
Monofilament Sensory Testing[40] Semmes Weinstein monofilaments applied to C6, C7, and C8 dermatomes of each hand to measure sensation
Berg Balance Scale[41] 56-point interval scale to measure balance while standing, transferring, and performing simple tasks
GaitRITE[35] Quantitative analysis of gait using an electronic pressure mat, measured with gait stability ratio (single stance time / double stance time)

Various clinical assessments were selected to comprehensively assess common neurological and functional impairments that occur in cervical myelopathy, including fine motor dysfunction of the hands, weakness, numbness, gait imbalance, and urinary difficulties.